Gilead breaks ground on manufacturing development site at California HQ

[Gilead sign at headquarters of Gilead Sciences biopharmaceutical company]
Michael Vi

* Gilead Sciences (NASDAQ:GILD [https://seekingalpha.com/symbol/GILD]) has broken ground on its Pharmaceutical Development and ManufacturingTechnical Development Center (NTDC) at the biotech's Foster City, Calif., headquarters.
* The building is part of the company's planned $32B [https://seekingalpha.com/news/4443572-gilead-to-invest-about-32b-in-us-manufacturing-through-2030] manufacturing and R&D investments in the U.S. through 2030.
* The 180,000-square-foot structure "will serve as a hub for innovation and collaboration across technical development and manufacturing teams," according to a Gilead news release [https://seekingalpha.com/pr/20219960-gilead-sciences-breaks-ground-on-new-manufacturing-hub-a-cornerstone-of-its-u-s-growth-and]. "Designed with flexible pilot lab space and advanced digital infrastructure, the NTDC will accelerate technology transfer and support the advancement of next-generation biologics across Gilead’s pipeline.
* "It will feature digitally enabled systems, autonomous robotics, and real-time digital monitoring, making it one of the most AI-enabled centers in the biopharma industry."
* Gilead is also developing two other buildings in Foster City. One is a research building under construction, while the other is a biologics manufacturing site.

MORE ON GILEAD SCIENCES

* Gilead Sciences: HIV Leadership Outshines Decline In COVID-19 Drug Sales [https://seekingalpha.com/article/4818501-gilead-sciences-hiv-leadership-outshines-decline-in-covid-19-drug-sales]
* From Stagnation To Surge: Gilead Sciences Is Entering Its Next Growth Wave [https://seekingalpha.com/article/4815477-from-stagnation-to-surge-gilead-sciences-is-entering-its-next-growth-wave]
* Gilead Sciences' Outperformance Means Overvalued [https://seekingalpha.com/article/4814444-gilead-sciences-outperformance-means-overvalued]
* Gilead is said to seek price hikes for HIV meds supplied for state AIDS drug programs [https://seekingalpha.com/news/4491391-gilead-eyes-price-hikes-hiv-meds-state-aids-programs]
* Gilead granted EU nod for twice-yearly HIV PrEP therapy [https://seekingalpha.com/news/4489097-gilead-twice-yearly-hiv-prep-drug-oked-eu]